National Institutes of Health Donates Protease Inhibitor Patent to UNITAID Medicines Patent Pool
By Mark Harrington On September 30, 2010 the U.S. National Institutes of Health (NIH) became the first research funder to license intellectual property rights to the Medicines Patent Pool essential to manufacturing anti-HIV protease inhibitors. The patent pool is an…